LOXL4 and breast carcinoma: This may be a reasonable event, since LOXL4 is known to be upregulated by a hypoxic condition (23), transforming growth factor (TGF)-β (24), and an EMT-core transcription factor ZEB1 (25), all of which are associated with the malignant conversion of breast cancers.